| Daniel | What line of work are you in? http://www.flyeauclaire.com/caverta-does-it-work caverta ranbaxy 100 J.P.Morgan cut its price target on the stock to $32 from$34, while Susquehanna International Group cut its target to $40from $43. Bofa Merrill Lynch cut its rating on the stock to"neutral," according to theflyonthewall.com. |
|